The Covid-19 Therapeutics Accelerator has announced the recipients of a total of $20mn.
In Brief:
-
These include the University of Washington, University of Oxford and La Jolla Institute for Immunology.
-
The accelerator was launched by Mastercard, the Bill & Melinda Gates Foundation and Wellcome.
-
It aims to speed the development of, and access to, therapies for Covid-19.
What does this mean?
Through the grants, the three institutions will seek to understand how existing drugs and antibodies will contribute to the solution for this global pandemic. The Bill & Melinda Gates Foundation has stressed that “sound science and shared data” are the way forward.
